Headlands Technologies LLC Takes Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Headlands Technologies LLC acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 4,531 shares of the company’s stock, valued at approximately $145,000.

A number of other hedge funds have also recently made changes to their positions in SGRY. State of New Jersey Common Pension Fund D grew its holdings in Surgery Partners by 13.2% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 78,130 shares of the company’s stock worth $2,499,000 after purchasing an additional 9,114 shares during the last quarter. New York State Common Retirement Fund lifted its holdings in shares of Surgery Partners by 12.7% during the 4th quarter. New York State Common Retirement Fund now owns 30,679 shares of the company’s stock valued at $981,000 after purchasing an additional 3,468 shares during the last quarter. Handelsbanken Fonder AB boosted its position in shares of Surgery Partners by 43.0% in the 4th quarter. Handelsbanken Fonder AB now owns 11,300 shares of the company’s stock worth $361,000 after purchasing an additional 3,400 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Surgery Partners by 46.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,380 shares of the company’s stock worth $492,000 after buying an additional 4,874 shares during the last quarter. Finally, Strs Ohio purchased a new position in Surgery Partners during the 4th quarter worth $51,000.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Thursday, February 29th. Citigroup decreased their price objective on shares of Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a research report on Tuesday, February 27th. StockNews.com raised shares of Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Barclays assumed coverage on shares of Surgery Partners in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price target for the company. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $43.63.

Surgery Partners Stock Performance

SGRY stock opened at $24.76 on Tuesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.57 and a current ratio of 1.71. Surgery Partners, Inc. has a fifty-two week low of $22.05 and a fifty-two week high of $45.79. The business has a 50 day moving average price of $28.30 and a 200 day moving average price of $29.78.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Monday, February 26th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. Surgery Partners had a positive return on equity of 3.65% and a negative net margin of 0.43%. The firm had revenue of $735.40 million for the quarter, compared to analysts’ expectations of $741.93 million. During the same quarter in the previous year, the firm posted $0.22 EPS. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. As a group, research analysts predict that Surgery Partners, Inc. will post 0.78 EPS for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Bradley R. Owens sold 1,040 shares of Surgery Partners stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $35.22, for a total value of $36,628.80. Following the completion of the sale, the insider now directly owns 73,149 shares of the company’s stock, valued at approximately $2,576,307.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Surgery Partners news, CEO Jason Eric Evans sold 5,780 shares of Surgery Partners stock in a transaction on Monday, February 12th. The shares were sold at an average price of $35.08, for a total value of $202,762.40. Following the completion of the transaction, the chief executive officer now owns 419,118 shares of the company’s stock, valued at $14,702,659.44. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Bradley R. Owens sold 1,040 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $35.22, for a total value of $36,628.80. Following the transaction, the insider now owns 73,149 shares of the company’s stock, valued at approximately $2,576,307.78. The disclosure for this sale can be found here. In the last three months, insiders sold 18,774 shares of company stock worth $608,352. 2.60% of the stock is owned by corporate insiders.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.